PhaseRx, Inc.
PZRX
PZRX was delisted on the 2nd of February, 2018.
6 hedge funds and large institutions have $50.5K invested in PhaseRx, Inc. in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
14% less funds holding
Funds holding: 7 → 6 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
79% less capital invested
Capital invested by funds: $237K → $50.5K (-$187K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$8.78K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$976 |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$886 |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$695 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$61K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$43K |
| 3 |
VF
Virtu Financial
New York
|
-$21.6K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RFC
1
Regions Financial Corp
Birmingham,
Alabama
| $25K | – | – | – |
|
|
VF
2
Virtu Financial
New York
| $18K | -$21.6K | -29,326 | -38% |
|
|
3
Bank of New York Mellon
New York
| $5K | +$8.78K | +11,891 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | +$695 | +942 | +50% |
|
|
PAM
5
Panagora Asset Management
Boston,
Massachusetts
| $1K | +$976 | +1,323 | New |
|
|
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $468 | +$886 | +1,200 | New |
|
|
7
Vanguard Group
Malvern,
Pennsylvania
| – | -$61K | -74,704 | Closed |
|
|
TSS
8
Two Sigma Securities
New York
| – | -$43K | -52,396 | Closed |
|
|
9
Citadel Advisors
Miami,
Florida
| – | -$16K | -19,512 | Closed |
|
PZRX Hedge Fund Activity: Q4 2017 in Review
6 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in PhaseRx, Inc. (PZRX) for Q4 2017, worth a combined $50.5K — down 79% from $237K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PZRX and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Bank of New York Mellon, opening a new position worth an estimated $8.78K. The largest seller was Vanguard Group, exiting entirely with an estimated $61K sold.
- 6 institutional investors held PhaseRx, Inc. (PZRX) as of Q4 2017, down from 7 in Q3 2017.
- Funds reported $50.5K of PhaseRx, Inc. stock for Q4 2017, down 79% quarter-over-quarter.
- 3 funds opened new PhaseRx, Inc. positions in Q4 2017 and 4 closed out, a net change of -1 holder.
- The largest PhaseRx, Inc. buyer in Q4 2017 was Bank of New York Mellon, an estimated $8.78K added.
- The largest PhaseRx, Inc. seller in Q4 2017 was Vanguard Group, an estimated $61K sold.
Based on aggregated 13F filings for Q4 2017.